نتایج جستجو برای: anti cd20

تعداد نتایج: 365619  

2013
Hideaki Kobayashi Yuka Matsunaga Yumiko Uchiyama Kenji Nagura Yasuhiko Komatsu

Cellular activity of BM-ca, a novel humanized anti-CD20 antibody, was quantitatively compared with that of two other anti-CD20 antibodies used for clinical practice, rituximab and ofatumumab. The results of a complement-dependent cytotoxicity (CDC) assay revealed that the strongest antibody was ofatumumab, followed by BM-ca, with rituximab being the weakest. Ofatumumab and BM-ca were effective ...

Journal: :Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002
Hakan Kaya Yi-Kong Keung Douglas Case Julia M Cruz James J Perry James E Radford David D Hurd

The major cause of treatment failure following high-dose therapy with autologous hematopoietic cell transplantation (AHCT) for low-grade lymphomas (non-Hodgkin's lymphoma [NHL]) is persistent disease or recurrence. Most patients whose disease progresses following AHCT have resistant disease and limited bone marrow reserve. In this setting, treatment options are limited and responses to conventi...

2017
Anna H. Turaj Khiyam Hussain Kerry L. Cox Matthew J.J. Rose-Zerilli James Testa Lekh N. Dahal H.T. Claude Chan Sonya James Vikki L. Field Matthew J. Carter Hyung J. Kim Jonathan J. West Lawrence J. Thomas Li-Zhen He Tibor Keler Peter W.M. Johnson Aymen Al-Shamkhani Stephen M. Thirdborough Stephen A. Beers Mark S. Cragg Martin J. Glennie Sean H. Lim

Monoclonal antibodies (mAbs) can destroy tumors by recruiting effectors such as myeloid cells, or targeting immunomodulatory receptors to promote cytotoxic T cell responses. Here, we examined the therapeutic potential of combining a direct tumor-targeting mAb, anti-CD20, with an extended panel of immunomodulatory mAbs. Only the anti-CD27/CD20 combination provided cures. This was apparent in mul...

2015
Lukáš Smolej

Introduction of targeted agents revolutionized the treatment of chronic lymphocytic leukemia (CLL) in the past decade. Addition of chimeric monoclonal anti-CD20 antibody rituximab to chemotherapy significantly improved efficacy including overall survival (OS) in untreated fit patients; humanized anti-CD52 antibody alemtuzumab and fully human anti-CD20 antibody ofatumumab lead to improvement in ...

2015
Hélène Carpenet Armelle Cuvillier Jacques Monteil Isabelle Quelven Serge Muyldermans

In recent years, the diagnostic and therapeutic uses of radioisotopes have shown significant progress. Immunoglobulin (Ig) appears to be a promising tracer, particularly due to its ability to target selected antigens. The main objective of this study is to optimize and assess an Ig radiolabeling method with Technetium 99m (99mTc), an attractive radioelement used widely for diagnostic imaging. M...

Journal: :Clinical Journal of the American Society of Nephrology 2015

Journal: :Multiple Sclerosis and Related Disorders 2020

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید